Spot on mate! Incredible Growth inside 2 x quarters with the CEO IV impact = significant growth and recurring revenue... And that was at the time of the 29 Feb (82 Payors) as below!! Also gives a little look into the first quarter 2024... Over 400% growth in DME Payors.
Cheers
MTM
Ann: 2023 Annual Report, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.020(7.55%) |
Mkt cap ! $71.46M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.5¢ | $48.55K | 190.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 2488 | 1 |
View Market Depth
| Last trade - 15.55pm 19/06/2024 (20 minute delay) ? |
| NXS (ASX) Chart |